Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
abatacept, Abbott, aberrancy, acetate, Actelion, aggressive, Alex, anifrolumab, anniversary, antimalarial, arthralgia, atacicept, attenuate, autoreactive, bankruptcy, belimumab, beta, blisibimod, blocker, Cayman, Cederboum, Celgene, civilian, cleanup, clearance, CNS, complementarity, composed, contaminated, correlate, cytokine, cytotoxic, Daphna, deconsolidation, Denmark, depot, disinterested, divestment, draft, Edna, Egypt, eighteen, elotuzumab, enthusiasm, epratuzumab, expiry, explicitly, exploring, extremist, Fas, feeling, fever, Finland, fired, forigerimod, gamma, graft, Gutman, Hal, heightened, heretofore, herewith, Hezbollah, Holland, idiotype, IFN, immunosuppression, immunosuppressive, impede, induction, instance, intervention, intramuscular, Invion, Iraq, irrespective, ISIL, Islamic, issuable, jihadist, Jordan, Lebanon, lesser, Leukemia, Levant, Liechtenstein, ligand, lupuzor, mAb, majeure, malaise, MedImmune, methotrexate, mice, mild, militia, Mintz, missile, moderate, modulation, noise, nose, nuclear, OECD, officially, opposed, panobinostat, parallel, Paran, Parenteral, pathogenic, peaceful, Peninsula, pleurisy, Privileged, prominent, radioactive, rash, rebel, relinquish, sequence, Sinai, sporadically, steroid, stringent, sublease, subset, suppressor, Syria, tabalumab, TGF, thalomide, threatened, Tikotsky, TNF, topical, turbulence, unadjusted, unaffiliated, unanticipated, unappealing, uncured, unpaid, unregistered, vitro, Vorinistat, waive, wastewater, water
Removed:
activityand, administering, Africa, aggravation, agitation, Amit, analog, antipsychotic, apathy, aproportion, Arab, arepreferred, arose, asfrontline, atypical, autologoushaematopoietic, bargain, basket, begin, border, bortezomibin, boycott, clarified, clause, cognitive, collectionof, complication, comprise, compromise, constipation, consume, conventional, core, cyclophosphamide, deal, deployment, depression, derecognition, deriving, derogate, dexamethasone, disturbing, doxorubicin, effectivein, emerging, emotional, emphasize, escalating, essence, exact, experiencing, extensively, facing, factor, faster, FDAbased, founding, fundamentally, gaon, generated, Giboov, Grossman, GSK, hasrecently, Hayehudim, Helsinki, hematologist, Hematology, Hereunder, Herzliya, hispro, hospitalization, hostility, Ichilov, immunological, improve, inhibit, inInternal, intensity, intention, intracellular, isunclear, lab, licensor, lifelong, Manchester, Marc, maximize, mechanismof, Medinat, melphalan, methylprednisolone, Mittelman, modern, modified, modulationof, mortality, Moshe, moved, murine, neighbor, neuropathy, noncompliance, North, notification, nowused, ofthalidomide, organelleresponsible, originating, owing, partially, PCT, perpetual, pioneering, potent, poverty, prednisone, prerequisite, Presidio, principle, prolong, prolonged, propensity, prospectively, proteasome, protected, protein, psychiatric, rated, ratesand, refractory, refractorydisease, regimenscontaining, relapse, release, remitting, renewal, renewed, replicated, resistant, respond, restriction, restructuring, Ronen, Sackler, schizophrenic, Shalvata, showing, Sourasky, sparingly, speaker, speech, stop, Strip, substitute, summarized, survive, synergisticwith, teratogenicity, tetracycline, thalidomide, thromboembolism, thrombophilia, tracing, Traditional, transplant, treatmentfor, trend, trustee, Twito, unlimited, unrecognized, URL, validated, vehicle, vincristine, VivoQuest, voluntarily, VTE, white
Filing tables
Filing exhibits
XTLB similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form F-3 (File No. 333-147024, File No. 333-153055 and File No. 333-194338) and Form S-8 (File No. 333-148085, File No. 333-148754 and File No. 333-154795) of XTL Biopharmaceuticals Ltd. of our report dated March 31, 2016, relating to the financial statements, which appears in this Form 20-F.
Tel Aviv, Israel | /s/ Kesselman & Kesselman |
March 31, 2016 | |
Certified Public Accountants (Isr.) | |
A member firm of PricewaterhouseCoopers International Limited |